Learn more about our Advocacy work.
Scott Whitaker, President and CEO of AdvaMed®, led a meeting of medtech CEOs and leaders with Secretary of Commerce Gina Raimondo to discuss semiconductor chip supply chain issues impacting the…
On patient safety, there is no substitution for the extensive training, knowledge, and expertise authorized servicers must have to maintain and repair complex medical technology.
Congress is considering the latest agreement between the FDA and the industry to help fund agency consideration of medical devices with user fees.
Today, AdvaMed® President and CEO Scott Whitaker issued a statement following the White House’s announcement that the federal government’s COVID-19 response would be reduced in the coming weeks without additional…
This evening, President Joe Biden addressed the nation on the state of the union, including our national response to the COVID-19 pandemic and his Cancer Moonshot initiative.
The Advanced Medical Technology Association® (AdvaMed®), working in the United Kingdom with the Medical Technology Group (MTG) and the Association of British HealthTech Industries (ABHI), commends the recent announcement by the UK Government of aggressive polices to address…
Today, AdvaMed® President and CEO Scott Whitaker applauded the White House’s Request for Information on policies to sustain diagnostic test manufacturing for COVID-19.
Last week, AdvaMed® President and CEO Scott Whitaker and Semiconductor Industry Association (SIA) President and CEO John Neuffer hosted a joint roundtable discussion that included dozens of industry leaders and…
Today, the Advanced Medical Technology Association® (AdvaMed®), the world’s largest trade organization representing medical technology manufacturers, released the following statements from President and CEO Scott Whitaker and Chairman of the…
Chairman and CEO of Edwards Lifesciences, Mike Mussallem joins AdvaMed®’s Scott Whitaker to discuss the dedication of those in the industry and how policy reform can help speed up the…